
Aren Karapetyan/LinkedIn
May 6, 2025, 09:21
Aren Karapetyan Highlights Clinical Impact of PLATO ACT 4 Trial in Anal Cancer Treatment
Aren Karapetyan, Oncology Resident at Yerevan State Medical University named after Mkhitar Heratsi, shared a post on LinkedIn:
“The PLATO ACT 4 trial demonstrates significant clinical benefits from reducing the IMRT dose in the treatment of anal cancer, marking a major step forward in optimizing anal cancer therapy.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 6, 2025, 08:52
May 6, 2025, 08:45
May 6, 2025, 08:41
May 6, 2025, 08:22
May 6, 2025, 08:20